Patient Choice Ghent Inc Norfolk, VA - 23517

Patient Choice Ghent Inc is categorized under Specialty Outpatient Clinics, Nec in Norfolk, VA and active since 1996.

Patient Choice Ghent Inc was established in 1996, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Specialty Outpatient Clinics, Nec business, which does work in the B2C market, and is classified as a Specialty Outpatient Clinics, Nec, under code number 621498 by the NAICS.

If you are seeking more information, feel free to contact Dr Frank Westmeyer at the company’s headquarters by writing to 957 West 21st St # East, Norfolk, Virginia VA 23517 or by phoning (757) 622-8358. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Patient Choice Ghent Inc
Contact Person: Dr Frank Westmeyer
Address: 957 West 21st St # East, Norfolk, Virginia 23517
Phone Number: (757) 622-8358
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1996
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Specialty Outpatient Clinics, Nec
SIC Code: 8093
NAICS Code: 621498
Share This Business:

Patient Choice Ghent Inc was started in 1996 to provide professional Specialty Outpatient Clinics, Nec under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Dr Frank Westmeyer for inquiries that concern Patient Choice Ghent Inc by calling the company number (757) 622-8358, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Patient Choice Ghent Inc can be found at the coordinates 36.872912,-76.300827 as well as the street address 957 West 21st St # East in Norfolk, Virginia 23517.

For its online presence, you may visit Patient Choice Ghent Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.